Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat-Reference-Cited by-同舟云学术

Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat

Published:2004-03-08 Issue:4 Volume:72 Page:264-267
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Laszlo Daniele,Agazzi Alberto,Goldhirsch Aron,Cinieri Saverio,Bertolini Francesco,Rabascio Cristina,Pruneri Giancarlo,Calabrese Liliana,Cocquio Angela,Martinelli Giovanni

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0902-4441.2003.00211.x/fullpdf

Reference9 articles.

1. Acute leukaemia in Jehovah's Witnesses;Cullis;Br J Haematol,1998

2. Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukaemia;Kerridge;Arch Intern Med,1997

3. Acute leukemia in Jehovah's Witnesses: difficulties in its management;Gomez-Almaguer;Rev Invest Clin,1990

4. Cytosine arabinoside with daunomycin or adriamycin for therapy of acute myelocytic leukemia: a CALGB sudy;Yates;Blood,1982

5. Should Jehovah's Witnesses be denied intensive chemotherapy for acute leukaemia;Goldberg;N Engl J Med,1990

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products;Leukemia Research Reports;2022

2. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia in a Jehovah's Witness in an outpatient setting: A case report;Current Problems in Cancer: Case Reports;2021-12

3. NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021;Journal of the National Comprehensive Cancer Network;2021-01-06

4. Treatment of acute leukaemia in adult Jehovah's Witnesses;British Journal of Haematology;2019-11-06

5. High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah’s Witnesses patients: a feasible option in the age of hematopoietic growth factors;Leukemia & Lymphoma;2019-02-18